Pharmacy

The FINANCIAL -- AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic...

The FINANCIAL -- The Board of Directors of Bristol-Myers Squibb Company declared an increase of 2.5% percent in the company’s...

The FINANCIAL -- The Bayer Group aims to significantly enhance its performance in the coming years and has set itself...

The FINANCIAL -- Roche announced new data from the Venclexta/Venclyxto (venetoclax) clinical development programme, including longer-term results from the phase...

The FINANCIAL -- Bristol-Myers Squibb Company announced it will transfer $3.8 billion of U.S. pension obligations through a full termination...

The FINANCIAL -- Sandoz, a Novartis division and one of the global leaders in biosimilars, announced a global resolution of...

The FINANCIAL -- Novel results based on data from the landmark EMPA-REG OUTCOME trial were published in the journal Circulation...

The FINANCIAl -- TOKYO – May 29, 2018 – Astellas Pharma Inc. announced, that the U.S. Food and Drug Administration...

The FINANCIAL -- World Health Assembly delegates today agreed an ambitious new strategic plan for the next five years.

The FINANCIAL -- Eli Lilly and Company and ARMO BioSciences, Inc. on May 10 announced a definitive agreement for Lilly...

The FINANCIAL -- Bayer announced on May 11 that Eylea (aflibercept solution for injection into the eye) has been approved...

The FINANCIAL -- Merck on May 1 announced financial results for the first quarter of 2018.

The FINANCIAL -- Novartis AG on May 1 announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act...

The FINANCIAL -- AbbVie announced financial results for the first quarter ended March 31, 2018.

The FINANCIAL -- Commenting on the Group’s sales, Roche CEO Severin Schwan said: “We have started the year with strong...